- Home
- CLLS vs TCMD Comparison
CLLS vs TCMD Comparison
Compare CLLS & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLLS | TCMD |
|---|---|---|
| Founded | 1999 | 1995 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 299.0M | 300.1M |
| IPO Year | 2007 | 2016 |
Fundamental Metrics
Financial Performance| Metric | CLLS | TCMD |
|---|---|---|
| Price | $4.39 | $28.86 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 4 |
| Target Price | $8.00 | ★ $23.25 |
| AVG Volume (30 Days) | 132.4K | ★ 416.2K |
| Earning Date | 11-07-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 18.66 |
| EPS | N/A | ★ 0.77 |
| Revenue | $82,551,000.00 | ★ $311,513,000.00 |
| Revenue This Year | $32.58 | $11.31 |
| Revenue Next Year | N/A | $8.83 |
| P/E Ratio | ★ N/A | $38.27 |
| Revenue Growth | ★ 129.04 | 9.28 |
| 52 Week Low | $1.10 | $8.61 |
| 52 Week High | $5.48 | $30.24 |
Technical Indicators
Market Signals| Indicator | CLLS | TCMD |
|---|---|---|
| Relative Strength Index (RSI) | 49.34 | 68.74 |
| Support Level | $4.47 | $28.00 |
| Resistance Level | $5.45 | $30.24 |
| Average True Range (ATR) | 0.30 | 1.03 |
| MACD | -0.12 | -0.14 |
| Stochastic Oscillator | 31.17 | 75.79 |
Price Performance
Historical ComparisonAbout CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.